<?xml version="1.0" encoding="UTF-8"?>
<compound>
  <id type="integer">4430</id>
  <title>T3D4376</title>
  <common-name>4-Hydroxyphenylpyruvic acid</common-name>
  <description>4-Hydroxyphenylpyruvic acid (4-HPPA) is a keto acid that is involved in the tyrosine catabolism pathway. It is a product of the enzyme (R)-4-hydroxyphenyllactate dehydrogenase [EC 1.1.1.222] and is formed during tyrosine metabolism. The conversion from tyrosine to 4-HPPA is catalyzed by tyrosine aminotransferase. Additionally, 4-HPPA can be converted to homogentisic acid which is one of the precursors to ochronotic pigment. The enzyme 4-hydroxyphenylpyruvic acid dioxygenase (HPD) catalyzes the reaction that converts 4-hydroxyphenylpyruvic acid to homogentisic acid. A deficiency in the catalytic activity of HPD is known to lead to tyrosinemia type III, an autosomal recessive disorder characterized by elevated levels of blood tyrosine and massive excretion of tyrosine derivatives into urine. It has been shown that hawkinsinuria, an autosomal dominant disorder characterized by the excretion of 'hawkinsin,' may also be a result of HPD deficiency  There are two isomers of HPPA, specifically 4HPPA and 3HPPA, of which 4HPPA is the most common. (A3451).</description>
  <cas>156-39-8</cas>
  <pubchem-id>979</pubchem-id>
  <chemical-formula>C9H8O4</chemical-formula>
  <weight nil="true"/>
  <appearance>White powder.</appearance>
  <melting-point>219 - 220°C</melting-point>
  <boiling-point></boiling-point>
  <density nil="true"/>
  <solubility></solubility>
  <specific-gravity nil="true"/>
  <flash-point nil="true"/>
  <vapour-pressure nil="true"/>
  <route-of-exposure nil="true"/>
  <target nil="true"/>
  <mechanism-of-toxicity nil="true"/>
  <metabolism nil="true"/>
  <toxicity nil="true"/>
  <lethaldose nil="true"/>
  <carcinogenicity>No indication of carcinogenicity to humans (not listed by IARC).</carcinogenicity>
  <use-source>This is an endogenously produced metabolite found in the human body. It is used in metabolic reactions, catabolic reactions or waste generation.</use-source>
  <min-risk-level nil="true"/>
  <health-effects nil="true"/>
  <symptoms nil="true"/>
  <treatment nil="true"/>
  <created-at type="dateTime">2014-08-29T06:36:56Z</created-at>
  <updated-at type="dateTime">2026-05-14T18:45:19Z</updated-at>
  <interacting-proteins nil="true"/>
  <wikipedia>Hydroxyphenylpyruvic acid</wikipedia>
  <uniprot-id nil="true"/>
  <kegg-compound-id>C01179</kegg-compound-id>
  <omim-id nil="true"/>
  <chebi-id>15999</chebi-id>
  <biocyc-id>P-HYDROXY-PHENYLPYRUVATE</biocyc-id>
  <ctd-id nil="true"/>
  <stitch-id nil="true"/>
  <drugbank-id>DB07718</drugbank-id>
  <pdb-id>ENO</pdb-id>
  <actor-id nil="true"/>
  <organism nil="true"/>
  <export type="boolean">true</export>
  <metabolizing-proteins nil="true"/>
  <transporting-proteins nil="true"/>
  <moldb-smiles>OC(=O)C(=O)CC1=CC=C(O)C=C1</moldb-smiles>
  <moldb-formula>C9H8O4</moldb-formula>
  <moldb-inchi>InChI=1S/C9H8O4/c10-7-3-1-6(2-4-7)5-8(11)9(12)13/h1-4,10H,5H2,(H,12,13)</moldb-inchi>
  <moldb-inchikey>KKADPXVIOXHVKN-UHFFFAOYSA-N</moldb-inchikey>
  <moldb-average-mass type="decimal">180.1574</moldb-average-mass>
  <moldb-mono-mass type="decimal">180.042258744</moldb-mono-mass>
  <origin>Endogenous</origin>
  <state>Solid</state>
  <logp>1.6</logp>
  <hmdb-id>HMDB00707</hmdb-id>
  <chembl-id>CHEMBL607712</chembl-id>
  <chemspider-id>954</chemspider-id>
  <structure-image-file-name nil="true"/>
  <structure-image-content-type nil="true"/>
  <structure-image-file-size type="integer" nil="true"/>
  <structure-image-updated-at type="dateTime" nil="true"/>
  <biodb-id nil="true"/>
  <synthesis-reference></synthesis-reference>
  <structure-image-caption nil="true"/>
  <chemdb-id>CHEM003336</chemdb-id>
  <dsstox-id>DTXSID80166017</dsstox-id>
  <toxcast-id nil="true"/>
  <stoff-ident-origin nil="true"/>
  <stoff-ident-id nil="true"/>
  <susdat-id>NS00015136</susdat-id>
  <iupac>3-(4-hydroxyphenyl)-2-oxopropanoic acid</iupac>
  <moldb-polar-surface-area>74.60000000000001</moldb-polar-surface-area>
  <moldb-refractivity>44.6925</moldb-refractivity>
  <moldb-polarizability>16.750960680327967</moldb-polarizability>
  <moldb-rotatable-bond-count>3</moldb-rotatable-bond-count>
  <moldb-acceptor-count>4</moldb-acceptor-count>
  <moldb-donor-count>2</moldb-donor-count>
  <moldb-pka-strongest-acidic>2.91496710599853</moldb-pka-strongest-acidic>
  <moldb-pka-strongest-basic>-5.958513128269975</moldb-pka-strongest-basic>
  <moldb-physiological-charge>-1</moldb-physiological-charge>
  <moldb-number-of-rings>1</moldb-number-of-rings>
  <moldb-alogps-logp>1.12</moldb-alogps-logp>
  <moldb-alogps-logs>-2.08</moldb-alogps-logs>
  <moldb-alogps-solubility>1.49e+00 g/l</moldb-alogps-solubility>
</compound>
